Hypercholesterolemia in prenatally androgen treated males contrasted with downregulated cholesterol biosynthesis pathway genes (HMGCS1, HMGCR, MVD, FDPS, SQLE, CYP51A1, HSD17B7, NSDHL and DHCR7). This evidence concerns the gene CYP51A1 and familial hypercholesterolemia.